本页面由Tiger Trade Technology Pte. Ltd.提供服务

Anaptysbio Inc

70.10
+1.562.28%
盘后70.100.00000.00%19:49 EDT
成交量:46.03万
成交额:3,185.75万
市值:20.15亿
市盈率:-152.35
高:70.11
开:67.79
低:66.82
收:68.54
52周最高:70.11
52周最低:16.03
股本:2,874.83万
流通股本:1,725.90万
量比:1.01
换手率:2.67%
股息:- -
股息率:- -
每股收益(TTM):-0.4601
每股收益(LYR):-0.4601
净资产收益率:-24.49%
总资产收益率:7.06%
市净率:54.16
市盈率(LYR):-152.35

数据加载中...

2024/02/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/15

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/05

重要事件披露

Form 8-K - Current report
2023/11/28

重要事件披露

Form 8-K - Current report
2023/11/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/02

重要事件披露

Form 8-K - Current report
2023/11/02

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/10/26

重要事件披露

Form 8-K - Current report
2023/10/10

重要事件披露

Form 8-K - Current report
2023/10/02

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/09/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/19

重要事件披露

Form 8-K - Current report
2023/09/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/07

重要事件披露

Form 8-K - Current report
2023/08/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/06/16

重要事件披露

Form 8-K - Current report